facebooktwitterlinkedin
Health Resources Hub / Weight Management / Obesity

Finding the Right Obesity Medication Starts With Looking at the Whole Patient

Sherrie Singh-Bryan, Pharm.D., explains why choosing the right obesity medication requires evaluating the whole patient, and why medication is just one of four essential pillars of lasting obesity treatment.

By

Lana Pine

Published on July 22, 2026

Fact checked by:

Afton Woodward

4 min read

When it comes to treating obesity with medication, one size does not fit all. That is the core message from Sherrie Singh-Bryan, Pharm.D., a clinical pharmacist at Winn Army Community Hospital and member of the Obesity Medicine Association, who sat down with The Educated Patient to discuss what patients and their doctors should actually be thinking about when navigating the growing landscape of obesity treatment options.

More Than Just a Name on a Label

The first thing Singh-Bryan wants patients to understand is that obesity medications differ in ways that go far beyond brand names. Each drug class carries its own set of additional benefits that can make one option more appropriate than another, depending on what else a patient is managing.

She offered two vivid examples. A patient who is beginning their obesity treatment journey but also struggles with migraines may find that one particular weight loss medication doubles as a migraine prevention treatment. A patient who has been diagnosed with fatty liver disease may benefit from a medication that has received a specific indication to address that condition alongside weight. These nuances, she explained, are exactly why the decision cannot be made in isolation.

The Obesity Medicine Association recommends evaluating coexisting conditions as part of every obesity treatment plan, and Singh-Bryan echoes that guidance firmly. The goal, she said, is to look at the whole patient, not just the number on the scale.

A Tool in a Larger Toolkit

Describing obesity medication as a tool rather than a cure is not just a phrase. It reflects a framework that Singh-Bryan applies directly with her patients, one that divides obesity management into four interconnected pillars: physical, nutritional, psychological and medical intervention.

The medical piece, whether that is medication or surgery, is only one component. The other three require active, ongoing participation from the patient. She uses the analogy of a fitness tracker to make the point. Buying the watch does not make you move more. You have to show up and use it.

The same logic applies to obesity treatment. A medication can reduce appetite, support metabolic function and provide meaningful clinical benefit, but it cannot do the work of examining what your plate looks like, building a consistent movement habit or understanding the emotional relationship you have with food. Singh-Bryan encourages patients to ask themselves when certain eating habits began, what triggers them and what a healthier version of those patterns might look like. That kind of self-awareness, she said, is where lasting results actually come from.

Obesity, she noted, is now recognized as a chronic disease, not a personal failing, and it should be managed accordingly. The goal is not rapid weight loss. In fact, she cautioned against it. Losing weight too quickly often leads to regaining it just as fast. Realistic, patient goal setting, like losing 4 pounds over four to five weeks and sustaining it, is worth far more than dramatic short-term results that do not hold.

Her message to anyone beginning this journey is clear: Medication can be a powerful part of the plan, but you are still the one driving. The medication is the car. You are behind the wheel.

© 2026 MJH Life Sciences®

All rights reserved.